Category: Oncology/Hematology
North America Oncology/Hematology
-
U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030. Market Segmentation U.S. Pancreatic Cancer Diagnostics Market, By Test ... Read More
-
North America Optical Imaging Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Technique, By Application, By Therapeutic Area (Oncology, Ophthalmology, Cardiology, Dermatology, Neurology), By Country and Growth Forecast, 2022 - 2028
... - 2028 The North America Optical Imaging Market would witness market growth of 11.7% CAGR during the forecast period (2022-2028). Modern cell biology is quickly advancing in preclinical and clinical contexts, with new methods, contrast ... Read More
-
HER-2 Negative Breast Cancer Market, By Type of Treatment (Chemotherapy, Radiation, Hormonal Therapy, and Other Types of Treatments) and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Outlook, and Opportunity Analysis, 2023 - 2030 HER2-negative negative breast cancer means that the cancerous cells do not contain high levels of the protein HER2. Cancer cells that are HER2 negative may grow more slowly ... Read More
-
Cancer Supportive Care Products Market, By Drug Class (Nonsteroidal Anti – Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor), By Indication(Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies), and By Region( North America, Latin America, Europe, Asia Pacific, Middle East & Africa)- Size, Share, Outlook, ... Read More
-
2023 Mexico Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines ... Read More
-
2023 Global Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Europe, Japan - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The ... Read More
-
United States Solid Tumor Testing Market, By Type (Conventional Testing, Non-Conventional Testing (Fluorescence in-situ hybridization (FISH), Immunohistochemistry (IHC), Polymerase chain reaction (PCR), and Next-generation sequencing (NGS)); By Cancer Type (Prostate, Breast, Endometrial, Lung, Brain, Others); By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 United States Solid Tumor Testing Market Size Expanding to Reach USD 10.3 Billion ... Read More
-
2023 North America Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - US, Canada, Mexico - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 3-country report from LeadingMarketResearch.com. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into ... Read More
-
2023 Canada Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Cancer Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Yttrium-90 (Y-90), Fluorine-18 (18F), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... (18F), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, ... Read More
-
Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))
... Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa ... Read More
-
North America Medical Terahertz Technology Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Terahertz Imaging and Terahertz Spectroscopy) and Application (Oncology, Dentistry, Dermatology, Tomography, Biochemistry, and Others)
... medical terahertz technology market is expected to grow from US$ 54.65 million in 2022 to US$ 142.26 million by 2028. It is estimated to grow at a CAGR of 17.3% from 2022 to 2028. Rising ... Read More
-
United States Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings (Instruments, Reagents & Consumables, and Services), and Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer)
... Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings ... Read More
-
North America Gastric Cancer Diagnostic Procedure Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Healthcare Providers (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Types (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings (Instruments, Reagents & Consumables, and Services), and Disease Indication (Early Gastric Cancer and Advanced Gastric Cancer)
... Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedures (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offerings ... Read More
-
2023 Global Molecular Diagnostics Market in the US, Europe, Japan - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More
-
CAR T Cell Therapy Market, By Targeted Antigen (CD19, BCMA, HER2, GD2, CD20, CD22, CD30, CD33, HER1, Others (CLDN18, etc.)), By Therapeutic Application (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Glioblastoma, Sarcoma, Neuroblastoma, Acute Myeloid Leukemia, Breast Cancer, Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Others (Gastric Cancer, etc.)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle ... Read More
-
2023 Canada Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Mexico Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2023 Global Cancer Diagnostics Market in the USA, Europe, Japan-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... and analysis not available from any other published source , including 2022 supplier strategies and shares by country, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists ... Read More
-
2023 North America Cancer Diagnostics Market in the USA, Canada, Mexico-2022 Supplier Shares and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... information and analysis not available from any other published source , including 2022 supplier strategies and shares by country, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive ... Read More
-
2023 US Cancer Diagnostics Market-2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... published source , including 2022 supplier strategies and shares, and 2022-2027 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
NA Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent ... Read More
-
NA Brain Cancer Diagnostic Market - Industry Trends and Forecast to 2030
... Neuroma, Astrocytomas, Glioblastoma Multiforme, Meningiomas, Oligodendroglioma, and Others), Age Group (Below 21,21-34, 35-65, and 65 and Above), End User (Hospitals, Specialty Clinics, Diagnostic Centers & Research Institutes, Ambulatory Surgical Centers, and Others), Country (U.S., Canada, ... Read More
-
NA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, and Mexico) Industry ... Read More
-
NA Kidney Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type (Renal Cell Carcinoma, Clear cell renal cell carcinoma, non-clear cell renal cell carcinoma), Product (Platform-Based Products, Instrument based products, Kits and Reagents, and Other Consumables), Technology ... Read More
Research Assistance
